NCT00629551 - An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder | Biotech Hunter

Enrollment

825

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Depressive Disorder, Major

Interventions

DRUG

saredutant (SR48968)

oral administration,capsules

DRUG

paroxetine

oral administration, capsules

DRUG

placebo

oral administration, capsules

Trial Locations (8)

Sanofi-Aventis Administrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Tallinn

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, México

Sanofi-Aventis Administrative Office, Moscow

Sanofi-Aventis Administrative Office, Midrand

Sanofi-Aventis Administrative Office, Seoul